Assessing the consequences of gestational diabetes mellitus on offspring's cardiovascular health: MySweetHeart Cohort study protocol, Switzerland

Stefano Di Bernardo, Yvan Mivelaz, Adina Mihaela Epure, Yvan Vial, Umberto Simeoni, Pascal Bovet, Sandrine Estoppey Younes, Arnaud Chiolero, Nicole Sekarski, MySweetHeart Research Group, Stefano Di Bernardo, Yvan Mivelaz, Adina Mihaela Epure, Yvan Vial, Umberto Simeoni, Pascal Bovet, Sandrine Estoppey Younes, Arnaud Chiolero, Nicole Sekarski, MySweetHeart Research Group

Abstract

Introduction: Gestational diabetes mellitus (GDM) is a state of glucose intolerance with onset during pregnancy. GDM carries prenatal and perinatal risks as well as long-term risks for the mother and her child. GDM may be involved in the foetal programming of long-term cardiovascular health. However, evidence is sparse and the effect of GDM on cardiovascular health is unknown. To address these issues, we will conduct MySweetHeart Cohort study. The objectives are to assess the effect of GDM on offspring's cardiovascular health early in life by using surrogate markers of cardiovascular disease and atherosclerosis.

Methods and analysis: This is a cohort study of 100 offspring of women with GDM and 100 offspring of women without GDM. At inclusion, a baseline assessment of the mothers will be conducted through means of self-report questionnaires, a researcher-administrated interview, blood pressure and anthropometric measurements, and a maternal blood sampling. Between the 30th and 34th weeks of gestation, a foetal echography will be performed to assess the foetal cardiac structure and function, the fetomaternal circulation and the hepatic volume. At birth, maternal and neonatal characteristics will be assessed. An echocardiography will be performed to assess cardiac structure and function 2-7 days after birth; carotid intima-media thickness will be also measured to assess vascular structure. MySweetHeart Cohort is linked to MySweetHeart Trial (clinicaltrials.gov/ct2/show/NCT02890693), a randomised controlled trial assessing the effect of a multidimensional interdisciplinary lifestyle and psychosocial intervention to improve the cardiometabolic and mental health of women with GDM and their offspring. A long-term follow-up of children is planned.

Ethics and dissemination: Ethical approval has been obtained through the state Human Research Ethics Committee of the Canton de Vaud (study number 2016-00745). We aim to disseminate the findings through regional, national and international conferences and through peer-reviewed journals.

Trial registration number: ClinicalTrials.gov (clinicaltrials.gov/ct2/show/NCT02872974).

Keywords: cardiovascular disease; carotid intima-media thickness; foetal programming; left ventricular mass index; paediatric.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
Hypothetical and highly simplified causal relationships between gestational diabetes mellitus (GDM) and cardiometabolic disorders. Two pathways can be hypothesised: (1) a direct effect of GDM on offspring’s cardiometabolic disorders; (2) an indirect effect through the mediator large for gestational age (LGA). It means that if LGA was prevented, part of the effect of GDM on cardiometabolic disorders would be prevented. Several confounding factors (such as maternal obesity, weight gain during pregnancy, smoking, socioeconomic status or family history of cardiometabolic diseases) have to be accounted.

References

    1. Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am 2007;34:173–99. 10.1016/j.ogc.2007.03.002
    1. Albrecht SS, Kuklina EV, Bansil P, et al. . Diabetes trends among delivery hospitalizations in the U.S., 1994-2004. Diabetes Care 2010;33:768–73. 10.2337/dc09-1801
    1. Metzger BE, Gabbe SG, Persson B, et al. . International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: response to weinert. Diabetes Care 2010;33:e98–82. 10.2337/dc10-0719
    1. Reece EA, Leguizamón G, Wiznitzer A. Gestational diabetes: the need for a common ground. Lancet 2009;373:1789–97. 10.1016/S0140-6736(09)60515-8
    1. Reece EA. The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2010;23:199–203. 10.3109/14767050903550659
    1. Noussitou P, Monbaron D, Vial Y, et al. . Gestational diabetes mellitus and the risk of metabolic syndrome: a population-based study in Lausanne, Switzerland. Diabetes Metab 2005;31:361–9. 10.1016/S1262-3636(07)70205-7
    1. Landon MB, Mele L, Spong CY, et al. . The relationship between maternal glycemia and perinatal outcome. Obstet Gynecol 2011;117:218–24. 10.1097/AOG.0b013e318203ebe0
    1. Ullmo S, Vial Y, Di Bernardo S, et al. . Pathologic ventricular hypertrophy in the offspring of diabetic mothers: a retrospective study. Eur Heart J 2007;28:1319–25. 10.1093/eurheartj/ehl416
    1. Nolan CJ. Controversies in gestational diabetes. Best Pract Res Clin Obstet Gynaecol 2011;25:37–49. 10.1016/j.bpobgyn.2010.10.004
    1. Metzger BE, Lowe LP, Dyer AR, et al. . Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991–2002. 10.1056/NEJMoa0707943
    1. Nolan CJ, Damm P, Prentki M. Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet 2011;378:169–81. 10.1016/S0140-6736(11)60614-4
    1. Crowther CA, Hiller JE, Moss JR, et al. . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477–86. 10.1056/NEJMoa042973
    1. Landon MB, Spong CY, Thom E, et al. . A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 2009;361:1339–48. 10.1056/NEJMoa0902430
    1. Leary J, Pettitt DJ, Jovanovic L. Gestational diabetes guidelines in a HAPO world. Best Pract Res Clin Endocrinol Metab 2010;24:673–85. 10.1016/j.beem.2010.05.009
    1. Landon MB. Is there a benefit to the treatment of mild gestational diabetes mellitus? Am J Obstet Gynecol 2010;202:649–53. 10.1016/j.ajog.2010.02.006
    1. Hillier TA, Vesco KK, Pedula KL, et al. . Screening for gestational diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2008;148:766–75. 10.7326/0003-4819-148-10-200805200-00009
    1. Tieu J, Middleton P, McPhee AJ, et al. . Screening and subsequent management for gestational diabetes for improving maternal and infant health. Cochrane Database Syst Rev 2010;7:CD007222 10.1002/14651858.CD007222.pub2
    1. Veille JC, Hanson R, Sivakoff M, et al. . Fetal cardiac size in normal, intrauterine growth retarded, and diabetic pregnancies. Am J Perinatol 1993;10:275–9. 10.1055/s-2007-994739
    1. Yajnik CS. Fetal programming of diabetes: still so much to learn!. Diabetes Care 2010;33:1146–8. 10.2337/dc10-0407
    1. Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev 2014;94:1027–76. 10.1152/physrev.00029.2013
    1. Simeoni U, Yzydorczyk C, Siddeek B, et al. . Epigenetics and neonatal nutrition. Early Hum Dev 2014;90(Suppl 2):S23–4. 10.1016/S0378-3782(14)50007-2
    1. Gluckman PD, Hanson MA, Cooper C, et al. . Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61–73. 10.1056/NEJMra0708473
    1. Hivert MF, Perng W, Watkins SM, et al. . Metabolomics in the developmental origins of obesity and its cardiometabolic consequences. J Dev Orig Health Dis 2015;6:65–78. 10.1017/S204017441500001X
    1. Kiserud T. Diabetes in pregnancy: scanning the wrong horizon? Ultrasound Obstet Gynecol 2010;36:266–7. 10.1002/uog.7758
    1. Kessler J, Rasmussen S, Godfrey K, et al. . Venous liver blood flow and regulation of human fetal growth: evidence from macrosomic fetuses. Am J Obstet Gynecol 2011;204:429.e1–7. 10.1016/j.ajog.2010.12.038
    1. Ebbing C, Rasmussen S, Kiserud T. Fetal hemodynamic development in macrosomic growth. Ultrasound Obstet Gynecol 2011;38:303–8. 10.1002/uog.9046
    1. Tchirikov M, Kertschanska S, Stürenberg HJ, et al. . Liver blood perfusion as a possible instrument for fetal growth regulation. Placenta 2002;23(Suppl A):S153–8. 10.1053/plac.2002.0810
    1. Mirghani H, Zayed R, Thomas L, et al. . Gestational diabetes mellitus: fetal liver length measurements between 21and 24 weeks' gestation. J Clin Ultrasound 2007;35:34–7. 10.1002/jcu.20294
    1. Anderson NG, Notley E, Graham P, et al. . Reproducibility of sonographic assessment of fetal liver length in diabetic pregnancies. Ultrasound Obstet Gynecol 2008;31:529–34. 10.1002/uog.5298
    1. Sorof JM, Alexandrov AV, Cardwell G, et al. . Carotid artery intimal-medial thickness and left ventricular hypertrophy in children with elevated blood pressure. Pediatrics 2003;111:61–6. 10.1542/peds.111.1.61
    1. Urbina EM, Williams RV, Alpert BS, et al. . Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 2009;54:919–50. 10.1161/HYPERTENSIONAHA.109.192639
    1. McGill HC, McMahan CA, Gidding SS. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation 2008;117:1216–27. 10.1161/CIRCULATIONAHA.107.717033
    1. McGill HC, McMahan CA, Gidding SS. Are pediatricians responsible for prevention of adult cardiovascular disease? Nat Clin Pract Cardiovasc Med 2009;6:10–11. 10.1038/ncpcardio1389
    1. Simonetti GD, VON Vigier RO, Wühl E, et al. . Ambulatory arterial stiffness index is increased in hypertensive childhood disease. Pediatr Res 2008;64:303–7. 10.1203/PDR.0b013e31817d9bc5
    1. Chiolero A, Paradis G, Lambert M. Accuracy of oscillometric devices in children and adults. Blood Press 2010;19:254–9. 10.3109/08037051003606439
    1. El Assaad MA, Topouchian JA, Darné BM, et al. . Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit 2002;7:237–41. 10.1097/00126097-200208000-00006
    1. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit 2001;6:107–10. 10.1097/00126097-200104000-00007
    1. Braegger C, Jenni O, Konrad D, et al. . Nouvelles courbes de croissance pour la Suisse. Paediatrica 2011;22:9–11.
    1. de Onis M, Garza C, Victora CG, et al. . The WHO Multicentre Growth Reference Study. Food Nutr Bull 2004;25(1 Suppl):3–84.
    1. Fichtlscherer S, De Rosa S, Fox H, et al. . Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107:677–84. 10.1161/CIRCRESAHA.109.215566
    1. Salomon LJ, Alfirevic Z, Berghella V, et al. . Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol 2011;37:116–26. 10.1002/uog.8831
    1. Lee W, Allan L, Carvalho JS, et al. . ISUOG consensus statement: what constitutes a fetal echocardiogram? Ultrasound Obstet Gynecol 2008;32:239–42. 10.1002/uog.6115
    1. Tutschek B, Schmidt KG. Techniques for assessing cardiac output and fetal cardiac function. Semin Fetal Neonatal Med 2011;16:13–21. 10.1016/j.siny.2010.09.005
    1. Papageorghiou AT, Ohuma EO, Altman DG, et al. . International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet 2014;384:869–79. 10.1016/S0140-6736(14)61490-2
    1. Hadlock FP, Harrist RB, Sharman RS, et al. . Estimation of fetal weight with the use of head, body, and femur measurements–a prospective study. Am J Obstet Gynecol 1985;151:333–7. 10.1016/0002-9378(85)90298-4
    1. Salomon LJ, Bernard JP, Ville Y. Estimation of fetal weight: reference range at 20-36 weeks’ gestation and comparison with actual birth-weight reference range. Ultrasound Obstet Gynecol 2007;29:550–5. 10.1002/uog.4019
    1. Gagnon C, Bigras JL, Fouron JC, et al. . Reference Values and Z Scores for Pulsed-Wave Doppler and M-Mode Measurements in Fetal Echocardiography. J Am Soc Echocardiogr 2016;29:448–60. 10.1016/j.echo.2016.01.002
    1. Boito SM, Struijk PC, Ursem NT, et al. . Assessment of fetal liver volume and umbilical venous volume flow in pregnancies complicated by insulin-dependent diabetes mellitus. BJOG 2003;110:1007–13. 10.1111/j.1471-0528.2003.02533.x
    1. Ebbing C, Rasmussen S, Kiserud T. Middle cerebral artery blood flow velocities and pulsatility index and the cerebroplacental pulsatility ratio: longitudinal reference ranges and terms for serial measurements. Ultrasound Obstet Gynecol 2007;30:287–96. 10.1002/uog.4088
    1. Gómez O, Figueras F, Fernández S, et al. . Reference ranges for uterine artery mean pulsatility index at 11-41 weeks of gestation. Ultrasound Obstet Gynecol 2008;32:128–32. 10.1002/uog.5315
    1. Reichek N, Helak J, Plappert T, et al. . Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation 1983;67:348–52. 10.1161/01.CIR.67.2.348
    1. Lai WW, Geva T, Shirali GS, et al. . Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 2006;19:1413–30. 10.1016/j.echo.2006.09.001
    1. Lopez L, Colan SD, Frommelt PC, et al. . Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 2010;23:465–95. 10.1016/j.echo.2010.03.019
    1. Daubeney PE, Blackstone EH, Weintraub RG, et al. . Relationship of the dimension of cardiac structures to body size: an echocardiographic study in normal infants and children. Cardiol Young 1999;9:402–10. 10.1017/S1047951100005217
    1. Pettersen MD, Du W, Skeens ME, et al. . Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr 2008;21:922–34. 10.1016/j.echo.2008.02.006
    1. Haycock GB, Schwartz GJ, Wisotsky DH. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 1978;93:62–6. 10.1016/S0022-3476(78)80601-5
    1. Sass C, Herbeth B, Chapet O, et al. . Intima-media thickness and diameter of carotid and femoral arteries in children, adolescents and adults from the Stanislas cohort: effect of age, sex, anthropometry and blood pressure. J Hypertens 1998;16:1593-602–602.
    1. Jourdan C, Wühl E, Litwin M, et al. . Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents. J Hypertens 2005;23:1707–15. 10.1097/01.hjh.0000178834.26353.d5
    1. Mivelaz Y, Di Bernardo S, Boulos Ksontini T, et al. . Feasibility and reliability of carotid intima-media thickness measurements in nonsedated infants. J Hypertens 2016;34:2227–32. 10.1097/HJH.0000000000001065
    1. Maggio AB, Aggoun Y, Marchand LM, et al. . Associations among obesity, blood pressure, and left ventricular mass. J Pediatr 2008;152:489–93. 10.1016/j.jpeds.2007.10.042
    1. VanderWeele TJ, Mumford SL, Schisterman EF. Conditioning on intermediates in perinatal epidemiology. Epidemiology 2012;23:1–9. 10.1097/EDE.0b013e31823aca5d
    1. Chiolero A, Kaufman JS, Paradis G. Why adjustment for current weight can bias the estimate of the effect of birth weight on blood pressure: shedding light using causal graphs. J Hypertens 2012;30:1042–5. 10.1097/HJH.0b013e3283526663
    1. Vohr BR, Boney CM. Gestational diabetes: the forerunner for the development of maternal and childhood obesity and metabolic syndrome? J Matern Fetal Neonatal Med 2008;21:149–57. 10.1080/14767050801929430

Source: PubMed

3
S'abonner